Studies suggest that the high expression of GLYATL1 is related to the improvement of overall survival of renal clear cell carcinoma, liver cancer, bladder cancer, cervical cancer, lung cancer, ovarian cancer and other tumors (27, 28). Here, GLYATL1 is linked to ovarian carcinoma.